1. Home
  2. NVGS vs CRVS Comparison

NVGS vs CRVS Comparison

Compare NVGS & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navigator Holdings Ltd. (Marshall Islands)

NVGS

Navigator Holdings Ltd. (Marshall Islands)

HOLD

Current Price

$21.67

Market Cap

1.4B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVGS
CRVS
Founded
1997
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
NVGS
CRVS
Price
$21.67
$12.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$21.50
$30.17
AVG Volume (30 Days)
448.3K
1.5M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.30%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.66
$3.55
52 Week High
$24.36
$26.95

Technical Indicators

Market Signals
Indicator
NVGS
CRVS
Relative Strength Index (RSI) 42.59 39.05
Support Level $17.38 $11.42
Resistance Level $24.36 $19.21
Average True Range (ATR) 0.63 1.02
MACD -0.31 -0.11
Stochastic Oscillator 7.96 17.13

Price Performance

Historical Comparison
NVGS
CRVS

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: